Compare CZWI & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CZWI | CVRX |
|---|---|---|
| Founded | 1938 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.7M | 171.7M |
| IPO Year | 2006 | 2021 |
| Metric | CZWI | CVRX |
|---|---|---|
| Price | $17.56 | $8.24 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $11.20 |
| AVG Volume (30 Days) | 48.1K | ★ 412.8K |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.35% | N/A |
| EPS Growth | 8.96 | ★ 23.02 |
| EPS | ★ 1.46 | N/A |
| Revenue | N/A | ★ $56,651,000.00 |
| Revenue This Year | $13.02 | $16.78 |
| Revenue Next Year | $9.42 | $19.82 |
| P/E Ratio | $17.53 | ★ N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $12.69 | $4.37 |
| 52 Week High | $19.11 | $13.34 |
| Indicator | CZWI | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.00 | 63.39 |
| Support Level | $17.44 | $6.76 |
| Resistance Level | $18.90 | $9.06 |
| Average True Range (ATR) | 0.56 | 0.65 |
| MACD | -0.08 | 0.25 |
| Stochastic Oscillator | 19.05 | 89.35 |
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short- term investments; and funds provided from operations.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.